Heart Disease
-
100Plus webinar recap: How physician practices can implement an RPM program and succeed
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and reimbursement.
-
Artificial Intelligence, Health Tech
Mayo Clinic finds algorithm helped clinicians detect heart disease, as part of broader AI diagnostics push
Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It’s part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
NorthShore, Sema4 set up genomics program to advance personalized treatment
The Illinois-based health system is teaming up with the analytics company to launch a genomics program, which will focus on predicting the risk of illness and outcomes among patients. It will also provide free genetic testing to low-income patients in an effort to increase access to genomic care.
-
Cardiologist’s digital health startup raises $8.2M
Heartbeat Health, a digital health startup to help patients manage heart disease, raised $8.2 million in series A funding. The platform offers telehealth visits and helps patients keep track of their heart health by pulling in metrics from wearables and other devices.
-
Artificial Intelligence, Diagnostics
Startup says algorithm identifies new risk factor for heart disease but a doctor is skeptical
The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.
-
Michigan medtech company raises $77M for renal denervation solution to hypertension
While the development of renal denervation technologies stalled after a failed Medtronic study in 2014, recent positive research results have led to increasing interest – and investment – in the space.
-
Exclusive: Digital health company HeartFlow gets Japanese reimbursement approval for cardiac diagnostic tech
The new Japanese reimbursement policy will go into effect on Dec. 1 and follows positive coverage decisions by Medicare and the United Kingdom’s National Health Services.
-
Mayo Clinic, Eko pair up on machine learning tech to screen for heart diseases
The tool harnesses Mayo Clinic’s cardiovascular database and expertise in heart disease screening combined with Eko’s cardiac monitoring platform.
-
FDA nod to Apple Watch notable, but …
Apple Watch’s entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Quest Diagnostics’ Cleveland HeartLab acquisition reflects personalized medicine trend
In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
-
Color Genomics adds first cardiovascular test but is it adding value or a needless expense?
Color Genomics’ latest test highlights the quandary of genetic testing colliding with value-based care: Is the push to test taking preventive medicine in the wrong direction?
-
Proteomics shows promise for assessing risk of heart attacks and strokes
In a study published in JAMA, researchers at UCSF used an innovative protein measurement assay developed by healthcare technology company SomaLogic to detect 1,130 different proteins in the plasma of nearly 2,000 individuals already diagnosed with coronary heart disease.
-
CardioFocus gets appoval for HeartLight endoscopic ablation system
The HeartLight system allows electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with high procedural flexibility.
-
Goldman Sachs throws in $37M with Chinese replacement heart valve maker Venus Medtech
The Venus P-valve pulmonary replacement has already been implanted in more than 40 patients, and the current goal is to win CE Mark approval. They will reportedly be enrolling patients to accomplish this in the early half of the year.
-
Is the hope for a lifelong-lasting artificial heart a lost cause after previous failed attempts?
In the early ’80s, people got hyped about a potential artificial heart implant option for those who ideally would need transplants but didn’t have them available – namely the Jarvik-7. But doubt has since permeated after many failed attempts.